Related references
Note: Only part of the references are listed.Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy
Chien-Hung Chiu et al.
DISEASES OF THE ESOPHAGUS (2016)
Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil
Shau-Hsuan Li et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells
Guoke Liu et al.
CANCER LETTERS (2016)
Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC
Kun Ding et al.
ONCOLOGY REPORTS (2015)
Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma
Shau-Hsuan Li et al.
SURGERY (2015)
Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
Sheng-Dean Luo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer
Lui Ng et al.
STEM CELLS INTERNATIONAL (2015)
Overexpressed Ostepontin-c as a Potential Biomarker for Esophageal Squamous Cell Carcinoma
Mei-Xiang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
A comparative study of isolated and metachronous oesophageal squamous cell carcinoma with antecedent upper aerodigestive tract cancer
Hung-I Lu et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2013)
Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma
Shau-Hsuan Li et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2012)
Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma
Shau-Hsuan Li et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer
Tao Gu et al.
LUNG CANCER (2009)
Osteopontin expression in squamous cell cancer of the esophagus
I-Chen Wu et al.
WORLD JOURNAL OF SURGERY (2008)
Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000-05): Preliminary results
O. Bouche et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:: FFCD 9102
Laurent Bedenne et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of Osteopontin in oesophageal squamous cell carcinoma
Y. Kita et al.
BRITISH JOURNAL OF CANCER (2006)
Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line
Xiao Xia Wang et al.
CELL RESEARCH (2006)
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
AC Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
M Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical significance of osteopontin in esophageal squamous cell carcinoma: Comparison with common tumor markers
Y Shimada et al.
ONCOLOGY (2005)
Share Paper
